Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer

Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer

Abstract Background Use of natural products has been proposed as an efficient method in modulation of immune system and treatment of cancers. The aim of this study was to investigate the potential of cryptotanshinone (CPT), naringenin, and their combination in modulating the immune response towards...

Full description

Bibliographic Details
Main Authors: Shokoofe Noori, Mitra Nourbakhsh, Hossein Imani, Niloofar Deravi, Niloufar Salehi, Zohreh Abdolvahabi
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Naringenin
Cryptotanshinone
Immunomodulator
Regulatory T cells
STAT3
Breast cancer
Online Access:https://doi.org/10.1186/s12906-022-03625-x

Internet

https://doi.org/10.1186/s12906-022-03625-x

Similar Items